PreprintPDF Available

Rapid Validated Thin-Layer Chromatography–Densitometry for the Simultaneous Determination of Three Co-formulated Drugs Used for Common Cold Treatment

Authors:
Preprints and early-stage research may not have been peer reviewed yet.

Abstract and Figures

A rapid validated thin-layer chromatography (TLC)-densito-metric method has been developed for the simultaneous determination of 3 co-formulated drugs used for common cold and cough treatment. The studied drugs are paracetamol, pseudoephedrine, and chlorpheniramine maleate. The separation was achieved using silica gel 60 F 254 plates and the developing system of metha-nol-toluene-acetic acid (44:16:1, v/v). Densitometry scanning was performed at 254 nm. The method was validated as per the International Conference on Harmonization (ICH) guidelines and was successfully applied for the analysis of pharmaceutical preparation containing the cited ternary mixture without interference from excipients. There is no previously published TLC-densitometric method for the determination of the previously mentioned ternary mixture. The suggested method is rapid and of low cost, so it can be used for quality control analysis.
Content may be subject to copyright.
Journal of Pla nar Chromatography 29 (2016) 3 127
Summary
A rapid validated thin-layer chromatography (TLC)‒densito-
metric method has been developed for the simultaneous determ i-
nation of 3 co-formulated drugs used for common cold and cough
treatment. The studied drugs are paracetamol, pseudoephedrine,
and chlor pheniramine maleate. The separation was achieved us-
ing silica gel 60 F254 plates and the developing system of metha-
nol‒toluene‒acetic acid (44:16:1, v/ v). Densitometry scanning was
performed at 254 nm. The method was val idated as per the Inter-
national Conference on Harmonization (ICH) guidelines and was
successfully applied for the analysis of pharmaceutical preparation
containing the cited ternary mixture without interference from
excipients. There is no previously published TLC–densitometric
method for the determination of the previously mentioned ternary
mixture. The suggested method is rapid and of low cost, so it can be
used for quality control analysis.
1 Introduction
Paracetamol (PARA), pseudoephedrine (PSE), and chlorphe-
niramine maleate (CPM) have been co-formulated and widely
used for symptomatic treatment of common cold [1, 2]. Par-
acetamol, N-(4-hydroxyphenyl)acetamide, is an analgesic and
antipyretic agent. Pseudoephedrine, 2-methylamino-1-phenyl-
propan-1-ol, is used as a nasal mucosal vasoconstrictor and
M.M. Fouad and C.M. El-Maraghy, Analy tical Che mistry Depa rtment, Facult y
of Pharmacy, October Un iversity for Modern Sciences and Arts (MSA), Egypt;
and M.M. Fouad, Analytical C hemist ry Depart ment, Faculty of Phar macy,
Al-Azhar University, Egypt.
*E-mail: Christine_elmaraghy@hotmail.com; cmagued@msa.eun.eg
decongestant [3]. Chlorpheniramine maleate, 2-pyridinepro-
panamine-(4-chlorophenyl)-N,N-dimethyl-2-butenedioate, is a
reversible competitive inhibitor of the interaction of histamine
with H1 receptors [3]. The structures of these compounds are
shown in Figure 1. The literature review revealed their simul-
         
plasma, including spectrophotometry for the determination
of PSE, CPM, and dextromethorphan (DX) [4], chemometric
methods for the determination of PARA, CPM, and guaiphen-
esin [5], high-performance liquid chromatography (HPLC) for
the determination of PARA, CPM, and PSE in pharmaceuticals
[6–9], and HPLC–mass spectrometry (MS) for their analysis
        -
edge, there was no reported thin-layer chromatography (TLC)–
densitometric method for the simultaneous determination of
PARA, PSE, and CPM. The TLC method has the advantages
over the HPLC method of being more cost- and time-saving
and not requiring pH adjustment of the mobile phase or tedious
 
conduct a comparative study between TLC– densitometry and
the previously published HPLC method for the simultaneous

pharmaceutical preparation.
Rapid Validated Thin-Layer Chromatography–Densitometry
for the Simultaneous Determination of Three Co-formulated
Drugs Used for Common Cold Treatment
Manal M. Fouad and Christine M. El-Maraghy*
Key Words:
Paracetamol
Pseudoephedrine
Chlorpheniramine maleate
Thin-layer chromatography–densitometry
Common cold
Journal of Pla nar Chromatography 32 (2019) 2, 127–131 DOI: 10.155 6/10 06 .2019.3 2. 2.8
09 33- 4173 © Akadémiai Kiadó, Budapest
Figure 1
The chemical structures of paracetamol, pseudoephedrine hydro-
chloride, and chlorpheniramine maleate.
TLC–Densitometric Determination of Three Co-formulated Drugs Used for Common Cold
128 Journal of Planar Chromatography 32 (2019) 2
2 Experimental
2.1 Instruments
A CAMAG TLC scanner (CAMAG, Muttenz, Switzerland)
operated with winCATS software version 3.15, a Linomat
         
(Hamilton, Bonaduz, Switzerland), and pre-coated silica gel
254

2.2 Reagents and Chemicals
Paracetamol (El Nasr Company, Cairo, Egypt), chlorphe-
niramine maleate (ADWIC Pharmaceutical Company, Egypt),
and pseudoephedrine hydrochloride (Delta Pharma Company,
         
respectively, as stated by the supplier were used.
Methanol (Riedel-de Haën, Sigma-Aldrich, Darmstadt, Ger-
   
glacial acetic acid (ADWIC) were used.
2.3 Pharmaceutical Preparation
Cetal Cold&Flu®      


2.4 Preparation of Standard Solutions
 for
PARA and 1 mg mL for PSE and CPM were prepared using
       
freshly prepared by dilution with methanol to obtain solutions
having concentrations of 1 mg mL  
for PSE and CPM.
2.5 Procedures
2.5.1 Chromatographic Conditions
-
  254 aluminum sheets. The samples were applied to
    

from each other and 2 cm from the bottom edge. A mixture of
methanol, toluene, and acetic acid (44:16:1, v/v) was selected
as the mobile phase. Densitometry scanning was performed at
254 nm. The chromatographic chamber was pre-saturated with


2.5.2 Construction of Calibration Curves
-
ing standard solutions of each drug separately, equivalent to

        
plates, and the previous conditions were applied. The relative
         -
ing concentration, from which the regression equations were
calculated.
2.5.3 Assay of Laboratory-Prepared Mixtures
  


each drug in the laboratory-prepared mixtures were calculated
and processed as described. The concentration of the 3 drugs
was calculated using the corresponding calculated regression
equation.
2.5.4 Application to Pharmaceutical Preparation
Ten Cetal Cold&Flu® tablets were accurately weighted and
 
            -
          
      
            
-

 
 PSE. The general pro-
cedure described above was followed, and the concentrations of
PARA, CPM, and PSE were calculated using the corresponding
regression equation. The validity of the results was assessed by
      
concentrations of the 3 pure drugs to the same pharmaceuti-
cal preparation and proceeding as the previously mentioned
procedure.
3 Results and Discussion
         
method for the simultaneous determination of 3 co-formulated
-
         
was no reported TLC–densitometric method for the simultane-
ous determination of PARA, PSE, and CPM. TLC–densitom-
 
instr ument and the solvents used), and rapid, when compared
to HPLC.
Figure 2
TLC densitogram of PARA (60 μg per spot), CPM (20 μg per spot),
and PSE (20 μg per spot), using methanol –tolu ene–acetic acid
(44:16:1, v/v) as the developing system measured at 254 nm.
TLC–Densitometric Determination of Three Co-formulated Drugs Used for Common Cold
Journal of Pla nar Chromatography 32 (2019) 2 129
3.1 Method Optimization
The chromatographic conditions were optimized by spotting
-
tems in order to achieve the best separation. Initially, a system
  v/v) was used, but PARA was
very near to the solvent front. Increasing the polarity of the
developing system by increasing the methanol ratio was done
in order to move PARA away from the solvent front. Acetic acid

error in the retardation factor (RF) calculation. Complete sepa-

acetic acid in a ratio of 44:16:1 (v/v). The average RF values of

Figures 2‒5.
3.2 Method Validation
The Inter national Conference on Harmonization (ICH) guide-
lines [13] for method validation were followed.
3.2.1 Linearity
Calibration graphs were found to be linear in the range of


3.2.2 Accuracy
The accuracy of the proposed chromatographic method was

standard solution of PARA, CPM, and PSE in triplicate. Their
concentrations were calculated using the corresponding regres-
sion equation, and then the mean percentage recovery and
the standard deviation (%RSD) were calculated, as shown in
Table 1.
3.2.3 Precision
          
drugs were analyzed on the same day to determine the intra-
 
each concentration were analyzed for 3 separate days by using
the developed chromatographic method and calculating the rel-
ative standard deviation (Table 1).
3.2.4 Specicity
 
     
PARA, CPM, and PSE. Satisfactor y results were obtained as
shown in Table 2.
3.2.5 Robustness
The robustness was investigated by analysis of samples under
small changes in the mobile phase ratio to 42:18:1 (v/v), by
changing the mobile phase volume and the time of the mobile
Figure 4
TLC densitogram of PARA (RF = 0.81 ± 0.02) in the concentration
range of 50– 600 μg per spot.
Figure 5
TLC densitogram of CPM (RF = 0.1 ± 0.01) in the concentration range
1–30 μg per spot.
Figure 3
TLC densitogram of PSE (RF = 0.71 ± 0.02) in the concentration
range of 10–35 μg per spot.
TLC–Densitometric Determination of Three Co-formulated Drugs Used for Common Cold
130 Jo urnal of Planar Chromatography 32 (2019) 2
          
the chromatographic resolution. The results indicated that the

small deliberate variations (Table 3).
Tab le 1
Regression parameters for the determination of PARA, CPM, and
PSE using TLC–densitometry.
Parameters
TLC–densitometry
PA R A CPM PSE
Linearity range
]   
Slope 212.75 1771.9 6 93.14
Intercept 1587. 2 3515 
SE of the slope  95.615 
SE of the intercept 191.83   
Standard deviation of
residuals   76.67 
r)  
]
]
19.7
48.6


 

Accur acy
%RSD)  
Precision
(%RSD)
Inter-day 1.54 1.23 1.67
Intra-day 1.89 1.75 
The inter-day and int ra-day precision values of the samples: PARA


Tab le 2
Results obtained for the analysis of laboratory-prepared mixtures,
by the proposed methods, for the determination of PARA, CPM, and
PSE.
Conc.
( PAR – C PM – PS E)
%Recoverya)
PAR CPM PSE
 99.67 9 8.17 
     
      
   
b) 98.54 99.77 98.77
   
a)Average of three determinations
b)The ratio of Cetal Cold&Flu® pharmaceutical preparation
Tab le 3
Robustness of the proposed TLC–densitometric method for the de-
termination of PARA, CPM, and PSE.
Parameter
PA R A CPM PSE
RF
Mobile phase composition
[methanol–toluene –acetic acid]
(42:18:1, v/v)
v/v)






Mobile phase volume
   
Duration of saturation
   
Tab le 4
System suitability parameters of the develope d TLC– densitometric
method.
Parameter
TLC–densitometry
PA R A CPM PSE
RF   
Tailing factor (T)  
Selectivity factor (α)7.66 1.15
Resolut ion (Rs) 2.2 2.45
Tab le 5
Quantitative d etermination of PARA, CPM, and PSE in the phar-
maceutical preparation and application of standard addition tech-
nique.
Pharmaceutical
Preparation laimed Added
 %Recoverya)
Cetal Cold&Flu® tablets

Each labeled to contain

PARA, 2 mg CPM,

PA R A







99.72
 
CPM


3
4
5



 
PSE


1
2
3
98.54
99. 31
99.75
 
a)Average of 3 determinations. The values between parentheses repre-
sent the %Recovery and SD of analysis of pharmaceutical preparation
TLC–Densitometric Determination of Three Co-formulated Drugs Used for Common Cold
Journal of Pla nar Chromatography 32 (2019) 2 131
3.3 System Suitability
       
        
Method performance data including retardation factor (RF),
tailing factor (T), and resolution (Rs) are listed in Table 4.
3.4 Analysis of Pharmaceutical Preparation
The proposed method was applied for the determination of
PARA, CPM, and PSE in Cetal Cold&Flu® tablets. The results
were satisfactor y and in good agreement within the labeled
amount. The interference of excipients in the pharmaceutical
preparation was studied using a standard addition technique.
According to the obtained results, good accuracy and preci-
sion were observed (Table 5). Consequently, the excipients
in the phar maceutical formulations did not interfere in the
simultaneous analysis of the 3 studied drugs in pharmaceutical
preparation.
3.5 Statistical Analysis
The results obtained by applying the proposed chromatographic
method were statistically compared to the reference HPLC
method [8]. The calculated t- and F-values were less than the
 

respect to accuracy and precision, as presented in Table 6.
4 Conclusion
-
titative analysis of PARA, PSE, and CPM in their laborato-
ry-prepared mixtures and in pharmaceutical formulations using
TLC–densitometry. The results showed that the developed
TLC–densitometry had the advantages of being simpler than
the HPLC, as it used simple mobile phase with no pH adjust-
ment, sensitive, and economic, as it saves cost (inexpensive
           
applied onto a single plate per one development). The developed
method can be used in routine quality control testing, allowing
qualitative and quantitative determination with high accuracy
and precision.
References
[1] A. Yacobi, R.G. Stoll, G.C. Chao, J.E. Carter, D.M. Baaske, B.L.
Kamath, A.H. Amann, C. M. Lai, J. Phar m. Sci. 69

[2] S.S. Chua, S.I. Benrimoj, R.D. Gordon, G. Williams, Br. J. Clin.
Phar macol. 31 
[3] L.L. Brunton, K.L. Parker, Goodman & Gilman’s Manual of
         

[4] J.L. Murtha, T.N. Julian, G.W. Radebaugh, J. Pharm. Sci. 77
(1988) 715 –718.
[5] A. Rohman, Y. Ardiyanti, S. Sudjadi, S. Riyanto, J. Med. Sci. 15

[6] V.R. Pyreddy, U.R. Mallu, V. Bobbarala, S. Penumajji, J. Pharm.
Res. 4
[7] F. A l- Rimaw i, Saudi Pharm. J. 18 
[8] S. Rajurkar, IJLPR 1
[9] H. Al-Akraa, N. Sarkis, M. Alshehaby, Int. J. Pharm. Pharm. Sci.
5
 H.-g. Lou, H. Yuan, Z.-r. Ruan, B. Jiang, J. Chromatogr. B 878

[11] Q. Liao, Z. Xie, B. Pan, C. Zhu, M. Yao, X. Xu, J. Wan, Chr omatog-
raphia 67
[12] H. Zou, S. Gao, W. Chen, Z. Yanqiang, J. Xuetao, P. Yuanying,
Chromatographia 68
[13] ICH, International Conference on Har monization, of Technical
Requirements for Registration of Pharmaceuticals for Human




Tab le 6
Statistical comparison bet ween th e results obtained by the proposed methods and reference method for the determination of PARA, CPM,
and PSE in pure powder form.
Parameter
TLC–densitometry Reference methodb)
PA R A CPM PSE PA R A CPM PSE
Mean 99.43 99.54 99. 21 98.99 9 9.21
SD 1.17 1.55 1.23  1.53 
 1.36  1.51  2.34 1.14
N 555 555
Student’s t-testa)   
F-testa)   
a)The values between parenthesis are the theoretical values of t- and F-test at P
b)The reference HPLC method using a C18              , 2 m L

... The purity was found to be (99.84%) and (99.71%) for RAN and MET, respectively according to the reported methods [15,16]. Methanol Analar (E. ...
... The developed method depended on the difference between values of retardation factor (R f ) [15,16] of RAN and MET because of the difference in their migration rates and in their polarities on the polar silica plates. The chromatographic conditions were optimized using different systems of solvent to reach the best separation of the two drugs. ...
... The zone (10) was yellow in TLC method and green in spectrophotometric methods due to the usage of ethyl acetate eluting solvent with NFPA health hazard rating 2. The zone (11) was yellow as the methanol and ethyl acetate have flammability hazard. The two zones (14) and (15) were red due to the waste volume was > 10 mL and were not treated. The results were shown in Table 6. ...
... The proposed method was based on the difference in Rf values [26] between CPM and LCF, which results from differences in their polarities and migration rates on silica plates. To achieve the best separation of the two drugs, different solvent systems were used to optimise the chromatographic conditions. ...
Article
Full-text available
Background The proposed research study introduces independent concentration extraction (ICE) as a novel UV–Vis spectrophotometric approach. The approach can be used for extracting the concentration of two analytes with severely overlapped spectra from their binary mixtures. ICE is based on spectral extraction platform involving simple smart successive methods that can directly extract the original zero order spectra of the analytes at their characteristic (λmax). Chlorpheniramine maleate (CPM) and Levocloperastine fendizoate (LCF) are two commonly co-formulated drugs in cough preparations. The combined mixture was used to confirm the validity of the developed ICE tool. Another less green HPTLC was developed for the first time to separate both drugs and help also in confirming the proposed tool. Methods For the simultaneous determination of CPM and LCF, two ecologically friendly techniques were employed. The first approach encompasses the use of the ICE spectrophotometric method that could be successively applied for extracting the concentration of two analytes with severely overlapped unresolved spectra in their binary mixtures. Other complementary methods aiming at original spectral extraction; including spectrum subtraction (SS) and unity subtraction (US) were also successfully employed to resolve the zero order spectra of the combined drugs with all their characteristic features and peaks. The second technique used, a high-performance TLC-densitometric one, was performed on silica plates with silica plates F254 and a mobile phase with a ratio of 3:3:3:1 by volume of toluene, ethanol, acetone, and ammonia as a developing system at 230 nm. Results The presented extraction approach was executed without any optimization steps or sample pretreatment for the simultaneous determination of CPM and LCF. The method was found to be valid for their determination within concentration range of 3.0–30.0 μg mL⁻¹ for both drugs. For HPTLC method, the resulting Rf values of CPM and LCF were 0.37 and 0.78, within concentration ranges of 0.3–4.0 μg/spot and 0.8–10.0 μg/spot, respectively. Greenness assessment of both developed methodologies showed that the HPTLC method is less green than the spectrophotometric method, yet with comparable sustainability when it comes to the used technique. Conclusion The procedures were found to be selective, accurate, and precise for analysis of the studied binary mixture. Furthermore, the environmental impact of the introduced methods was assessed using novel greenness metrics, namely AGREE and Green Analytical Procedure Index (GAPI) to prove their ecological safety. In addition, white analytical chemistry (WAC) evaluation metric was employed to ensure the synergy and coherence of analytical, practical, and ecological attributes.
... CPM has been measured in pharmaceutical formulations and biological fluids by RP-HPLC [13], HPTLC [14,15], capillary electrophoresis [16] and spectrophotometric methods [17,18] separately or in combination with other medicines. For simultaneous measurement of these medicines in tablet formulation, spectrophotometric techniques have been published [18]. ...
Article
Full-text available
One of the most prevalent over-the-counter cold and cough medications is the chlorpheniramine maleate (CPM)–ibuprofen (IBF) combination. A reversed-phase high-performance liquid chromatography (RP-HPLC) method was effectively optimized and developed for the simultaneous detection of chlorpheniramine maleate and ibuprofen in a pharmaceutical formulation. The mobile phase for the RP-HPLC method was an isocratic combination of acetonitrile and 0.01 M acetate buffer at pH 3.8 (55:45; v/v) on an Eclipse Plus C18 reversed phase column. An ultraviolet (UV) detector with a wavelength of 225 nm was used to detect the analytes at a flow rate of 1.0 mL/min. CPM and IBF were satisfactorily eluted, with mean retention times of 2.09 and 6.27 min, respectively. The approach was shown to be linear (R2 > 0.9998 for CPM and 0.9992 for IBF), precise (% RSD 3.02% for CPM and 3.48% for IBF), accurate (% recoveries 97.7–98.9% for CPM and 101–104.5% for IBF), specific, easy to use, sensitive, quick, and robust. Limits of detection (LODs) were found to be 10 and 27 μg/mL for CPM and IBF, respectively. Without interference from excipients, the validated method could be utilized in regular quality control analysis of various dosage combinations of hard gelatin capsules containing CPM and IBF.
Article
Biogenic amines (BAs) are compounds deemed to be foodstuff contaminants and are the cause of poisoning or allergy. The main BAs found in foods include histamine, tyramine, putrescine, cadaverine, spermine and spermidine. The number of poisoning cases related to BAs in food has increased, which is reinforcing the need for BAs detection to ensure food safety. BAs are found in varying quantities in different foods such as fish, fruits, meat, cheese, vegetables, beer, and wine. Currently, different analytical techniques are used for BAs detection, as well as sample treatment methods that allow greater sensitivity, higher analyzing speed and lower detection limits. Moreover, BAs can be precursors of nitrosamines, which have been associated with mutagenic and carcinogenic activity. This review aims to provide a general approach to the different detection techniques of the BAs in foods, their concentrations and treatment methods.
Article
Background Combination of paracetamol, pseudoephedrine, chlorpheniramine, and sodium benzoate in (Cold - Flu) 1,2,3 Syrup dosage form are specified for the treatment of common cold and flu symptoms. Objective The functional role of this study is to develop a novel, reliable, and selective stability-indicating RP-UPLC method for simultaneous identification of a quaternary mixture of paracetamol, pseudoephedrine, chlorpheniramine, and sodium benzoate in (Cold - Flu) 1,2,3 Syrup dosage form. Method: The specific method is accomplished on a stationary phase Acquity UPLC HSS T3 C18 column (2.1 mm × 100 mm) 1.8 µm with pore size 100Å and column void volume is 1.15 min, utilizing a mixture of purified water –methanol –trifluoroacetic acid (72.5:27.5:1.5, v/v) as the mobile phase at a flow rate of 0.3 mL/min and UPLC detection is adjusted at 205 nm using photodiode array detector (DAD). Results Calibration curves are obtained in the linearity range (25-500 µg/mL) of paracetamol, (10-50 µg/mL) of pseudoephedrine, (0.5-5 µg/mL) of chlorpheniramine, and (3-30 µg/mL) of sodium benzoate with a correlation coefficient > 0.9992, the mean recovery of the developed method is tested and showed good recovery results between (99- 101%), selectivity and forced degradation studies are investigated as per ICH guidelines and no interference is detected due to degradation peaks. Conclusions The proposed stability-indicating UPLC method for simultaneous determination of three drugs of paracetamol, pseudoephedrine, chlorpheniramine with a preservative sodium benzoate in (Cold - Flu) 1,2,3 Syrup dosage form is successfully accomplished, developed, and validated, and can be easily used in the analysis of drugs in pure or dosage form. Highlights The novelty of the current research work lies in the development of the UPLC method for simultaneous determination of a quaternary mixture of paracetamol, pseudoephedrine, chlorpheniramine, and sodium benzoate in (Cold - Flu) 1,2,3 Syrup dosage form.
Article
To construct a rapid read-out analytical platform for detecting histamine in foods, a self-visualization nanomaterial was prepared by stable doping of ninhydrin into TiO2 nanoparticles ([email protected]2) using a sol-gel strategy, and it was printed onto the target zone for histamine on a high-performance thin layer chromatography (HPTLC) strip based on the Rf value. Under the optimum TLC conditions, histamine in the sample migrates to the target zone, and the colorimetric reaction occurs in situ. The resultant color spots can be either identified visually or semi-quantitatively by image analysis. Owing to the stable visualization performance, the constructed strip demonstrated good contrast, with a low background and easily recognizable colored spots. The linear range was 15.0–320.0 mg kg⁻¹, and the limit of detection for histamine in fish was 5.0 mg kg⁻¹. Other biogenic amines such as putrescine and cadaverine did not interfere with the analysis. Furthermore, analytical results for fish samples were verified by HPLC tests, demonstrating the robustness and reliability of the developed method. Therefore, the incorporation of a self-visualization nanomaterial in the HPTLC platform is a promising strategy for the rapid analysis of food contaminants in the future.
Article
Full-text available
A simple, precise, and accurate method is developed and validated for the analysis of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol in tablet formulations. The method has shown adequate separation of the four ingredients from each other. Separation was achieved on a silica column (5 μm, 125 × 4.6 mm inner diameter) using a mobile phase consisting of methanol/ammonium dihydrogen phosphate buffer (90:10, v/v) at a flow rate of 1.0 ml/min and UV detection at 220 nm. This new method is validated in accordance with USP requirements for new methods for assay determination, which include accuracy, precision, selectivity, linearity and range, robustness and ruggedness. The current method demonstrates good linearity over the range of 0.15-0.45 mg/ml of pseudophedrine hydrochloride with r (2) of 0.996, and in the range of 0.075-0.225 mg/ml of dextromethorphan hydrobromide with r (2) of 0.992, and in the range of 0.01-0.03 mg/ml of chlorpheniramine maleate with r (2) of 0.994, and in the range of 0.25-0.75 mg/ml of paracetamol with r (2) of 0.991. The average recovery of the method is 99.7%, 98.6%, 98.1%, and 99.2% for pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol, respectively. The degree of reproducibility of the results obtained as a result of small deliberate variations in the method parameters and by changing analytical operator has proven that the method is robust and rugged.
Article
The method of choice for analysis of drugs in multi-component preparations is chromatographic based technique such as High Performance Liquid Chromatography (HPLC). However, chromatographic method is time consuming and requiring much effort. As a consequence, some simple methods such as UV spectrophotometry are continuously developed, especially in combination with the chemometrics software. The UV-vis spectrophotometry coupled with multivariate calibration of Partial Least Square (PLS) has been developed for quantitative analysis of paracetamol, guaiphenesin and chlopheniramine maleate in the presence of phenylpropanolamine without separation step. The calibration model is prepared by developing a series of sample mixture comprising these drugs in certain proportion. The evaluation of calibration model was based on coefficient of determination (R2) and Root Mean Square Error of Calibration (RMSEC). The result showed that UV spectrophotometry combined with PLS can be used for quantitative analysis of drugs. The coefficient of determination (R2) for the relationship between actual values and predicted values was higher than 0.99 indicating good accuracy. The RMSEC values obtained were relatively low indicating good precision. The accuracy of developed method was compared to that of HPLC. The developed method was successfully used for analysis of paracetamol, guaiphenesin and chlopheniramine maleate in tablet dosage form © 2015, Asian Network for Scientific Information. All rights reserved.
Article
This investigation compared the bioavailability of chlorpheniramine and pseudoephedrine from a sustained-action capsule and a combination of two reference standard tablets in 24 normal human subjects. The capsule contained 8 mg of chlorpheniramine maleate and 120 mg of pseudoephedrine hydrochloride, and the tablets each contained half of the amount of the chlorpheniramine or pseudoephedrine in the capsule. Because the capsule was a combination product, a new study design had to be developed to accommodate steady-state conditions for both drugs. Each subject received the capsule (every 12 hr) and the combination of the reference tablets (every 6 hr) for 8 days according to a two-way crossover design. Serial blood and urine samples were taken during the entire study. Plasma and urine samples were assayed for chlorpheniramine and pseudoephedrine by sensitive and specific high-pressure liquid chromatographic or GLC methods. There were no significant differences in the plasma concentration profiles of chlorpheniramine and pseudoephedrine at all times, except when the capsule developed peaks or the tablets developed nadirs. The highest mean peak plasma concentrations for the capsule and the tablets were 38.7 and 32.9 ng of chlorpheniramine/ml and 525 and 515 ng of pseudoephedrine/ml, respectively. The mean biological half-lives of chlorpheniramine and pseudoephedrine were 21.6 and 8.0 hr, respectively. The AUC and unchanged drug excreted in urine, after a single dose and at steady state, showed that the sustained-action capsule (given every 12 hr) and the reference standard tablets (given every 6 hr) were bioequivalent.
Article
A simple, rapid and sensitive liquid chromatography/electrospray tandem mass spectrometry quantitative detection method, using amantadine as internal standard, was developed for the simultaneous analysis of paracetamol, pseudoephedrine and chlorpheniramine concentrations. Analytes were extracted from plasma samples by liquid–liquid extraction with n-hexane–dichloromethane–2-propanol (2:1:0.1, v/v), separated on a C18 reversed-phase column with 0.1% formic acid–methanol (40:60, v/v) and detected by electrospray ionization mass spectrometry in positive multiple reaction monitoring mode. Calibration curves for plasma were linear over the concentration range 10–10,000ngmL−1 of paracetamol, 2–2,000ngmL−1 of pseudoephedrine and 0.2–200ngmL−1 of chlorpheniramine. The method has a lower limit of quantitation of 10ngmL−1 for paracetamol, 2.0ngmL−1 for pseudoephedrine and 0.2ngmL−1 for chlorpheniramine. Recoveries, precision and accuracy results indicate that the method was reliable within the analytical range, and the use of the internal standard was very effective for reproducibility by LC-MS-MS. This method is feasible for the evaluation of pharmacokinetic profiles of a novel multicomponent sustained release formulation containing 325mg of paracetamol, 30mg of pseudoephedrine hydrochloride and 2mg of chlorpheniramine maleate. It is the first time the pharmacokinetic evaluation of a novel sustained-action formulation containing paracetamol, pseudoephedrine and chlorpheniramine has been elucidated in vivo using LC-MS-MS.
Article
A liquid chromatography–tandem mass spectrometry (LC–MS–MS) method was developed for the simultaneous determination of paracetamol, pseudoephedrine and chlorpheniramine in human plasma. Diphenhydramine was used as the internal standard. Analytes were extracted from alkalized human plasma by liquid–liquid extraction (LLE) using ethyl acetate. After electrospray ionization positive ion fragments were detected in the selected reaction monitoring (SRM) mode with a triple quadrupole tandem mass spectrometer. The method was linear in the concentration range of 20.0–10000.0ng mL−1 for paracetamol, 1.0–500.0ng mL−1 for pseudoephedrine and 0.1–50.0ng mL−1 for chlorpheniramine. The intra- and inter-day precisions were below 14.5% and the bias was between −7.3 and +2.8% for all analytes. The validated LC–MS–MS method was applied to a pharmacokinetic study in which each healthy Chinese volunteer received a tablet containing 300mg benorylate, 30mg pseudoephedrine hydrochloride and 2mg chlorpheniramine maleate. This is the first assay method described for the simultaneous determination of paracetamol, pseudoephedrine and chlorpheniramine in human plasma samples.
Article
For the first time, a highly sensitive and simple LC-MS/MS method after one-step precipitation was developed and validated for the simultaneous determination of paracetamol (PA), pseudoephedrine (PE), dextrophan (DT) and chlorpheniramine (CP) in human plasma using diphenhydramine as internal standard (IS). The analytes and IS were separated on a YMC-ODS-AQ C(18) Column (100 mm x 2.0 mm, 3 microm) by a gradient program with mobile phase consisting of 0.3% (v/v) acetic acid and methanol at a flow rate of 0.30 mL/min. Detection was performed on a triple quadrupole tandem mass spectrometer via electrospray ionization in the positive ion mode. The method was validated and linear over the concentration range of 10-5000 ng/mL for PA, 2-1000 ng/mL for PE, 0.05-25 ng/mL for DT and 0.1-50 ng/mL for CP. The accuracies as determined from quality control samples were in range of -8.37% to 3.13% for all analytes. Intra-day and inter-day precision for all analytes were less than 11.54% and 14.35%, respectively. This validated method was successfully applied to a randomized, two-period cross-over bioequivalence study in 20 healthy Chinese volunteers receiving multicomponent formulations containing 325 mg of paracetamol, 30 mg of pseudoephedrine hydrochloride, 15 mg of dextromethorphan hydrobromide and 2 mg of chlorphenamine maleate.
Article
Twelve hypertensive patients who were classified as pseudoephedrine-sensitive in a preliminary trial were selected for further investigation with single doses of pseudoephedrine 60 mg, a combination of chlorpheniramine 4 mg with paracetamol 650 mg and placebo. A double-blind, randomised, crossover study design was followed. Treatment with pseudoephedrine produced significant effects on all the four variables measured (systolic, diastolic and mean arterial blood pressure, and heart rate). Effects of the chlorpheniramine/paracetamol combination were found to be not significantly different from placebo. It was concluded that the combination may be useful as a medication for 'colds' in hypertensive patients, since it does not induce cardiovascular effects such as those observed with pseudoephedrine.
Article
The simultaneous determination of the active ingredients in multicomponent pharmaceutical products normally requires the use of a separation technique, such as HPLC or GC, followed by quantitation. Presented here is a rapid, validated, analytical method that does not require prior separation for the simultaneous determination of three drugs, pseudoephedrine hydrochloride, chlorpheniramine maleate, and dextromethorphan hydrobromide, in a tablet formulation. A diode array spectrophotometer, capable of multicomponent analysis, was used for the quantitation. The utility of this method was demonstrated in two ways: the analysis of a chewable pediatric tablet (formulation CP) containing 7.5 mg of pseudoephedrine hydrochloride, 0.5 mg of chlorpheniramine maleate, and 2.5 mg of dextromethorphan hydrobromide, and the dissolution analysis of a hydroxypropyl methylcellulose-based sustained-release tablet (formulation SR) containing 120 mg of pseudoephedrine hydrochloride, 8 mg of chlorpheniramine maleate, and 60 mg of dextromethorphan hydrobromide. The sensitivity of this assay is 7.5 micrograms/mL for pseudoephedrine hydrochloride, 1.0 micrograms/mL for chlorpheniramine maleate, and 5.0 micrograms/mL for dextromethorphan hydrobromide, using the second-derivative spectra of the absorbance with respect to wavelength. Determinations were made in 0.1 M sodium acetate buffer at pH 5.0 using a 1-cm quartz cell. Absorbance spectra, and their first and second derivatives, from 240 to 300 nm were used for the determination. The results obtained by this method compared favorably with the results obtained by a validated HPLC method.
  • A Yacobi
  • R G Stoll
  • G C Chao
  • J E Carter
  • D M Baaske
  • B L Kamath
  • A H Amann
  • C M Lai
A. Yacobi, R.G. Stoll, G.C. Chao, J.E. Carter, D.M. Baaske, B.L. Kamath, A.H. Amann, C. M. Lai, J. Pharm. Sci. 69 (1980) 1077-1081.